Volume : 11, Issue : 06, June – 2024
Title:
FORMULATION AND EVALUATION OF METOPROLOL SUCCINATE TRANSDERMAL PATCHES
Authors :
G D. Vijay*, Dr. G. Gopi, Dr. P.K. Prakash Reddy
Abstract :
Bioadhesive systems provide intimate contact between a dosage form and the absorbing tissue, which may result in high concentration in a local area and hence high drug flux through the absorbing tissue. Example : Transdermal Drug Delivery system. The present study was carried out to investigate the Transdermal release of Metoprolol Succinate by Solvent Casting method using different polymers. From the results, it was found the liberation of drug from the formulations. All the Transdermal patches Pre-formulation and Post-formulation patches were found to be within the limits. Among all the formulations, F6 (with Sodium alginate, Gelatin, PVP K30, HPMC K4M, SLS, Urea, Tween 80 and Glycerine) emerged to be the best one, because, it exhibits the maximum percentage drug release of 98.15%. In-vitro kinetics for F6 showed that the drug mechanism was found to be Non-Fickian diffusion.
Cite This Article:
Please cite this article in press G D. Vijay et al., Formulation And Evaluation Of Metoprolol Succinate Transdermal Patches.,Indo Am. J. P. Sci, 2024; 11 (6).
Number of Downloads : 10
References:
1. https://en.wikipedia.org/wiki/Bioadhesive
2. https://global.hisamitsu/operations/tdds.html
3. https://www.google.com/search?q=anatomy+and+physiology+of+skin&rlz=1C1CHBF_enIN1000IN1000&oq=&aqs=chrome.0.69i59i450l8.335474254j0j1 5&sourceid=chrome&ie=UTF-8
4. https://www.ncbi.nlm.nih.gov/books/NBK470464/# NBK470464_dtls
5. https://www.mayoclinic.org/diseases-conditions/angina/symptoms-causes/syc-20369373
6. https://www.drugs.com/mtm/metoprololsuccinateer.html#:~:text=Metoprolol%20Succinate%20ER%20is%20a, be%20hospitalized%20for%20heart%20failure.
7. 7.S.Jayaprakash, S.M.Halith, K.Pillai, P.balasubramaniyam, U.M.Firthouse, and M.Boopathi,”Formulation and evaluation of bilayer tablets of amlodipine besilate and metoprolol succinate ,”Der Pharmaciea Lettre, vol.3,no.4,pp.143-154,2011.
8. Patel rakesh ,Patel Grishma, Patel Hitesh, Baria Ashok ”Formulation and Evaluation of Transdermal Patch of Aceclofenac” Research Journal of Pharmaceutical dosage forms and Technology. volume:1 page no:108, year 2009.
9. Shailesh T.Prajapati, Charmi G.Patel,and Chhagan N.Patel “Formulation and Evaluation of Transdermal Patch of Repaglinide. International Scholar Research Network ISRN Pharmaceutics vol.2011, Article ID651909, 9 Pages. Doi:10.5402/2011/651909.
10. Changshun Rena, b , Liang Fanga , Lei Lingb , Qiang wangb, sihai liub, Ligang et al. Design and invivo evaluation of an indapamide Transdermal Patch. International journal of pharmaceutics vol.370 , issues1-2 ,31 March 2009, pages129-135.
11. Bing cai et.al “Development and evaluation of a tampering resistant Transdermal fentanyl patch. International journal of pharmaceutics vol.488 issues 1-2 5th july2015 pages102-107.
12. Ai Fujiwara ,toshihiro Hinokitani, et al. “Partial ablation of Porcine strartum corneum by argon-fluoride excimer laser to enhance transdermal drug permeability. Published:18 December 2004.
13. Wikstrand,Jhon et al.”Pharmacokinetics Considerations of Formulations:Extended-Release Metoprolol Succinate in the Treatment of Failure.Journal of cardiovascular Pharmacology:February 2003-volume 41-issue 2-p 151-157.